The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The US Food and Drug Administration (FDA) has granted humanitarian device exemption for an implantable replacement heart in patients with end-stage biventricular heart failure who are not eligible for other treatment options; approval for an artificial intervertebral disc in the treatment of low back pain in patients who have no more than grade 1 spondylolisthesis and who have failed at least 6 months of conservative treatment; and approval for a diagnostic/ablation deflectable tip catheter in the treatment of adults with recurrent refractory sustained monomorphic ventricular tachycardia.

The device manufacturers are, as expected, quite pleased.

Comments are closed.

Of Interest